dry eyes; xerophthalmia; keratitis sicca; keratoconjunctivitis sicca
Jump to navigation
Jump to search
Etiology
- chronic inflammation
- Sjogren's syndrome (keratoconjunctivitis sicca)
- meibomian gland dysfuction is a major cause of evaporatic dry eyes[10]
- aging
Epidemiology
Pathology
- dimimished tear production from the lacrimal gland
Clinical manifestations
- red eye
- foreign body sensation
- reflex tearing
- eye discomfort or eye pain (even severe eye pain)[5]
- light senesitivity
- blurry vision
- eye pain & blurry vision improve with blinking or rubbing the eyes
- ref[11] cited as support that patient may present with watery eyes, but no mention of that found in cited ref
Complications
- patients with connective tissue disease, Graves disease, or Bell's palsy may develop corneal damage due to dry eyes & are at higher risk for corneal infection[3]
Management
- artificial tears may alleviate symptoms & improve vision[5]
- lubricating ointment at night if artifical tears alone not sufficient
- eyelid hygiene if lubricating ointment inadequate[5]
- restasis
- lifitegrast (Xiidra)
- omega-3 fatty acids of no benefit
- refer to ophthalmologist if conservative measures are unsuccessful[5]
More general terms
Additional terms
References
- ↑ Greater Los Angeles, GRECC, optometry
- ↑ Prescriber's Letter 10(4):23 2003
- ↑ 3.0 3.1 Medical Knowledge Self Assessment Program (MKSAP) 15, 16 American College of Physicians, Philadelphia 2009, 2012
- ↑ 4.0 4.1 Latkany R. Dry eyes: etiology and management. Curr Opin Ophthalmol. 2008 Jul;19(4):287-91 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18545008
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
Geriatric Review Syllabus, 10th edition (GRS10) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2019 - ↑ Wojtowicz JC, Arciniega JC, McCulley JP, Mootha VV. Effect of systane and optive on aqueous tear evaporation in patients with dry eye disease. Eye Contact Lens. 2010 Nov;36(6):358-60 PMID: https://www.ncbi.nlm.nih.gov/pubmed/ 21060260
- ↑ FDA News Release. July 12, 2016 FDA approves new medication for dry eye disease http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm510720.htm
- ↑ Clayton JA Dry Eye N Engl J Med 2018; 378:2212-2223. June 7, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29874529 https://www.nejm.org/doi/full/10.1056/NEJMra1407936
Rothaus C Dry Eye. NEJM Resident 360. June 6, 2018 https://resident360.nejm.org/content_items/dry-eye - ↑ Christen WG et al. Efficacy of marine omega-3 fatty acid supplementation vs placebo in reducing incidence of dry eye disease in healthy US adults: A randomized clinical trial. JAMA Ophthalmol 2022 Jul; 140:707 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35679030 PMCID: PMC9185512 (available on 2023-06-09) https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2793162
- ↑ 10.0 10.1 McCann P, Abraham AG, Mukhopadhyay A et al Prevalence and Incidence of Dry Eye and Meibomian Gland Dysfunction in the United States. A Systematic Review and Meta-analysis. JAMA Ophthalmol. Published online October 27, 2022 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36301551 https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2797832
- ↑ 11.0 11.1 Sharma RA, Mather R. Five things to know about...dry eye disease. CMAJ. 2014 Oct 7;186(14):1090. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24821862 PMCID: PMC4188654 Free PMC article. No abstract available.
- ↑ Dry Eye http://www.nei.nih.gov/health/cornealdisease/index.asp#d